Paul Y. Song, MD

Paul Y. Song, MD

Paul Y. Song, MD is the Chief Executive Officer and Chairman at NKGen Biotech, Inc. He has over 30 years of experience in the biotechnology and medical industry, with a focus on oncology, immunology, and therapeutic development.1

Key Positions

• Chief Executive Officer and Chairman, NKGen Biotech, Inc. (January 2023 - Present)1
• Vice Chairman of the Board, NKGen Biotech, Inc. (December 2021 - Present)1
• Co-Founder & CEO, Fuse Biotherapeutics (July 2021 - January 2023)1
• Chief Medical Advisor, Hawkeye Bio, Inc. (July 2017 - Present)1

Education and Training

• BA with honors, Biological Sciences, University of Chicago (1983 - 1987)1
• MD, The George Washington University School of Medicine and Health Sciences (1987 - 1991)1
• Chief Resident '95, Radiation and Cellular Oncology, The University of Chicago Pritzker School of Medicine (1992 - 1995)1
• ASTRO Research Fellow - Dept. of Radiation and Cellular Oncology, The University of Chicago Pritzker School of Medicine (1995 - 1996)1

Expertise

• Board Certified Radiation Oncologist1
• Skilled in Management, Translational Medicine, Clinical Trials, Regulatory Affairs, Medical Devices, Diagnostics, Governmental Affairs, and Healthcare Policy1

Dr. Song is a prominent figure in the biotech industry and has been actively involved in the fight against COVID-19, advocating for mask-wearing and raising awareness about the seriousness of the virus.2 His LinkedIn username is paul-y-song-md-7664147.1